review · Diabetes Metabolic Syndrome and Obesity
Diabetes mellitus is a chronic condition marked by high blood glucose levels resulting from disturbances in carbohydrate or lipid metabolism, or insulin function. It remains a major global cause of illness and death, with many individuals struggling to maintain healthy blood glucose levels and facing severe macrovascular and microvascular complications. Current disease management aims to keep blood glucose near normal, but there is an ongoing need to uncover new therapeutic targets to reduce the overall disease burden. Research highlights the critical role of inflammatory cascades in the progression of the disease. In particular, mediators of inflammation such as toll-like receptors have emerged as significant points of interest. Investigating these receptors provides a promising avenue for novel drug development strategies focused on preventing and controlling both diabetes and its related complications.
Diabetes affects millions globally and leads to debilitating cardiovascular and microvascular complications when blood sugar is poorly regulated. Exploring novel biological mechanisms, specifically toll-like receptors involved in inflammatory pathways, could help inform alternative therapies that improve patient outcomes and alleviate the heavy global healthcare burden associated with managing the condition and its secondary complications.
The work highlights toll-like receptors as conceptual drug targets for pharmaceutical developers and biotechnology teams seeking therapies for diabetes and related complications. Because the abstract describes an exploratory review of biological mechanisms, the research is at an early discovery stage. Substantial laboratory testing and clinical development will be required before these targets can yield tangible products for clinical use.
AI-generated from the published abstract. Always read the original work before citing.
Diabetes mellitus (DM) is a chronic endocrine disease distinguished by hyperglycemia due to disturbance in carbohydrate or lipid metabolism or insulin function. To date, diabetes, and its complications, is established as a global cause of morbidity and mortality. The intended aim during the management of diabetes is to maintain blood glucose close to normal because the majority of patients have poor control of their elevated blood glucose and are highly prone to severe macrovascular and microvascular complications. To decrease the burden of the disease and its complications, scientists from various disciplines are working intensively to identify novel and promising drug targets for diabetes and its complications. Increased and ongoing investigations on mechanisms relating to diabetes and associated complications could potentially consider inflammatory cascades as a promising component of the strategy in the prevention and control of diabetes and its complications. The potential of targeting mediators of inflammation like toll-like receptors (TLRs) are part of current investigation by the scientific community. Hence, the aim of the present review is to discuss the role of TLRs as a potential drug target for diabetes and diabetes associated complications.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.2147/dmso.s274844
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
